Sign In
Buy ZLAB
$17.17
+0.0200 (+0.117%)
At Close: Jun 03, 2026
SHANGHAI & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that the final overall survival (OS) data from the Phase 3 randomized, double-blind, placebo-co
Zai Lab Announces Participation in March Investor Conference
07:30am, Wednesday, 06'th Mar 2024
SHANGHAI & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that members of the Company's senior management team will participate in the following investor
Zai Lab Limited (ZLAB) Q4 2023 Earnings Call Transcript
02:37pm, Wednesday, 28'th Feb 2024
Zai Lab Limited (ZLAB) Q4 2023 Earnings Call Transcript
Top 5 Health Care Stocks That Are Preparing To Pump In February - CNS Pharma (NASDAQ:CNSP), Biolase (NASDAQ:BIOL)
08:35am, Friday, 09'th Feb 2024
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
Zai Lab to Announce Full-Year 2023 Financial Results and Recent Corporate Updates on February 27, 2024
04:15pm, Thursday, 25'th Jan 2024
SHANGHAI & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that it will report financial results for the year ended December 31, 2023 and recent corporate
SHANGHAI & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced The New England Journal of Medicine (NEJM) has published data from the registrational Phase 1/2
What Makes Zai Lab Limited Unsponsored ADR (ZLAB) a New Buy Stock
01:32pm, Friday, 22'nd Dec 2023
Zai Lab Limited Unsponsored ADR (ZLAB) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near ter
Zai Lab Announces Participation in January Investor Conference
07:30am, Tuesday, 19'th Dec 2023
SHANGHAI & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that members of the Company's senior management team will participate in the following investor
SHANGHAI & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that the 2023 National Reimbursement Drug List (NRDL) released by China's National Healthcare S
Zai Lab Limited (ZLAB) Q3 2023 Earnings Call Transcript
02:00pm, Wednesday, 08'th Nov 2023
Zai Lab Limited (NASDAQ:ZLAB ) Q3 2023 Earnings Conference Call November 8, 2023 8:00 AM ET Company Participants Christine Chiou - Senior Vice President-Investor Relations Samantha Du - Founder, Chair
Why Wall Street Thinks This Artificial Intelligence (AI) Stock Could Skyrocket 140% Over the Next 12 Months
05:50am, Monday, 16'th Oct 2023
This company uses AI to improve drug discovery for all of the 20 biggest biopharmaceutical companies. Even the most pessimistic analyst thinks the stock could jump nearly 32% over the next 12 months.
Betting Big: 3 Tech Stocks Primed for a Breakout
04:48pm, Thursday, 21'st Sep 2023
The fervor around tech stocks to buy now has been palpable this year, with several household names reaching unprecedented heights. However, with such meteoric runs, many investors are left wondering w
Zai Lab Stock: De-Risking Through Market Tapping
09:09am, Thursday, 07'th Sep 2023
Zai Lab Limited is a biotech company that acts as a powerful partner for other biotechs to launch drug candidates in China. They currently distribute four drugs in mainland China and have a pipeline o
Zai Lab ADR surges after Seagen, Genmab release cervical cancer treatment results
08:12am, Tuesday, 05'th Sep 2023
Zai Lab Ltd.'s American depositary receipts ZLAB, +2.47% jumped 14% premarket on Tuesday after Seagen Inc. SGEN, +0.89% and Genmab A/S GMAB, +0.24% announced that Tivdak, their treatment for cervical
Zai Lab Announces Participation in September Investor Conferences
07:38am, Tuesday, 29'th Aug 2023
SHANGHAI, China and CAMBRIDGE, Mass., Aug. 29, 2023 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that members of the company's senior management team will participate
